A Score to differentiate Takotsubo syndrome from non-ST-elevation myocardial nfarction in women at the bedside.


Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
2020
Historique:
received: 25 10 2019
revised: 02 01 2020
accepted: 03 02 2020
entrez: 24 3 2020
pubmed: 24 3 2020
medline: 24 3 2020
Statut: epublish

Résumé

A score to distinguish Takotsubo syndrome (TS) from acute coronary syndrome would be useful to facilitate appropriate patient investigation and management. This study sought to derive and validate a simple score using demographic, clinical and ECG data to distinguish women with non-ST elevation myocardial infarction (NSTEMI) from NSTE-TS. The derivation cohort consisted of women with NSTE-TS (n=100) and NSTEMI (n=100). Logistic regression was used to derive the score using ECG values available on the postacute ward round on day 1 post-hospital admission. The score was then temporally validated in subsequent consecutive patients with NSTE-TS (n=40) and NSTEMI (n=70). The five variables in the score and their relative weights were: T-wave inversion in ≥6 leads (+3), recent stress (+2), diabetes (-1), prior cardiovascular disease (-2) and ST-depression in any lead (-3). When calculated using ECG values obtained at admission, discrimination between conditions was very good (area under the curve (AUC) 0.87 95% CI 0.83 to 0.92). The optimal score cut-point of ≥1 to predict NSTE-TS had 73% sensitivity and 90% specificity. When applied to the validation cohort at admission, AUC was 0.82 (95% CI 0.75 to 0.90) and positive and negative predictive values were 78% and 81%, respectively. On day 1 post-admission, AUC was 0.92 (95% CI 0.87 to 0.97), with positive and negative predictive values of 77% and 91%, respectively. This NSTE-TS score is easy to use and may prove useful in clinical practice to distinguish women with NSTE-TS from NSTEMI. Further validation in external cohorts is needed.

Identifiants

pubmed: 32201588
doi: 10.1136/openhrt-2019-001197
pii: openhrt-2019-001197
pmc: PMC7066633
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Pagination

e001197

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Cardiology. 2012;121(4):228-36
pubmed: 22555306
Circulation. 2005 Feb 1;111(4):472-9
pubmed: 15687136
J Am Coll Cardiol. 2010 Feb 16;55(7):700-1
pubmed: 20170799
Am Heart J. 2008 Sep;156(3):543-8
pubmed: 18760139
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Nov;40(11):897-901
pubmed: 23363668
Int J Cardiol. 2011 Jan 21;146(2):256-8
pubmed: 21111497
Int J Cardiol. 2013 Jul 1;166(3):584-8
pubmed: 22192296
Am Heart J. 2008 Mar;155(3):408-17
pubmed: 18294473
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Heart. 2009 Feb;95(2):125-9
pubmed: 18381374
Intern Med. 2002 Oct;41(10):789-92
pubmed: 12412997
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
Heart Fail Clin. 2013 Apr;9(2):249-66, x
pubmed: 23562126
Eur Heart J. 2018 Jun 7;39(22):2032-2046
pubmed: 29850871
Eur Heart J. 1994 Nov;15(11):1571-84
pubmed: 7835374
Am J Cardiol. 2013 Aug 15;112(4):479-82
pubmed: 23683950
Circ J. 2003 Aug;67(8):687-90
pubmed: 12890911
J Am Coll Cardiol. 2017 Feb 7;69(5):570-591
pubmed: 28012615
N Z Med J. 2013 Dec 13;126(1387):69-80
pubmed: 24362735
Am J Cardiol. 2004 Aug 1;94(3):343-6
pubmed: 15276100
Eur J Heart Fail. 2017 Aug;19(8):1036-1042
pubmed: 27928880
Eur Heart J. 2016 Jan 14;37(3):267-315
pubmed: 26320110
Int J Cardiol. 2015 Nov 15;199:132-40
pubmed: 26188834
Am Heart J. 2009 May;157(5):933-8
pubmed: 19376324
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Am J Cardiol. 2008 Jun 15;101(12):1723-8
pubmed: 18549847
Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S89-100
pubmed: 9820468
JAMA Cardiol. 2016 Jun 1;1(3):335-40
pubmed: 27438117
Biom J. 2005 Aug;47(4):458-72
pubmed: 16161804
Am J Cardiol. 2003 Jul 15;92(2):230-3
pubmed: 12860233
J Am Coll Cardiol. 2007 Aug 14;50(7):647-9
pubmed: 17692751
Am J Cardiol. 2007 Jan 15;99(2):182-5
pubmed: 17223415
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
pubmed: 22958960
Aust N Z J Public Health. 2014 Jun;38(3):216-20
pubmed: 24890478

Auteurs

Jen-Li Looi (JL)

Cardiology, Middlemore Hospital, Auckland, New Zealand.

Katrina Poppe (K)

Epidemiology & Biostatistics, University of Auckland, Auckland, New Zealand.

Mildred Lee (M)

Cardiology, Middlemore Hospital, Auckland, New Zealand.

Jill Gilmore (J)

Cardiology, Middlemore Hospital, Auckland, New Zealand.

Mark Webster (M)

Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.

Andrew To (A)

Lakeview Cardiology Centre, North Shore Hospital, Auckland, New Zealand.

Andrew J Kerr (AJ)

Cardiology, Middlemore Hospital, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH